Children's Hospital Los Angeles
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Children's Hospital Los Angeles sits in the top decile of US sponsors by registered trial count (#218 of 15,742 sponsors by registered trial count).
Children's Hospital Los Angeles: 119 sponsored US clinical trials, 35 recruiting.
Children's Hospital Los Angeles sponsors 119 registered US clinical trials on ClinicalTrials.gov, 35 of them currently recruiting, and 62 completed. 8 of these trials are in Phase 3-4 (later-stage) and 20 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 4 trials.
Top-decile sponsor footprint
Children's Hospital Los Angeles ranks in the top decile of sponsors by registered trial count (#218 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
62 of 69 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
119 total, page 3 of 3
Nutrition and Body Composition in Acute Lymphoblastic Leukemia
NCT01317940
Iron Mediated Vascular Disease in Sickle Cell Anemia Patients
NCT01239901
Safety and Efficacy of Sodium Nitrite in Sickle Cell Disease
NCT01033227
A Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic Origin
NCT00993044
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
NCT00981370
Study to Evaluate Impact of School-based Influenza Vaccination on School Populations
NCT00844051
Changes in Pituitary Iron and Volume With Deferasirox
NCT01376622
Brown Fat Activity and White Fat Accumulation
NCT01517581
The UNBLOCK Study: Utilization of Bivalirudin On Clots in Kids
NCT00812370
Omegaven Treatment of Parenteral Nutrition (PN) Induced Liver Injury
NCT01089426
Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells
NCT00730314
Nebulized Hypertonic Saline for Bronchiolitis
NCT00619918
Is Chronic Abdominal Pain in Pediatric Patients Due to Small Intestinal Bacterial Overgrowth?
NCT00619970
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
NCT00412464
Activity and Content of Factor VIII (FVIII) in Human Plasma: The Assessment of a Novel Immunoassay
NCT00839202
Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia
NCT00140413
Vibration Intervention to Improve Bone and Muscle in Children With Cerebral Palsy
NCT00295295
Pediatric Fingertip Injuries:Are Antibiotics Required?
NCT00300092
Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma
NCT00006258
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 13 |
| Phase 2 | 7 |
| Phase 3 | 3 |
| Phase 4 | 5 |
What is open in the Children's Hospital Los Angeles pipeline
35 recruiting of 119 indexed (29% open); 62 completed (52%).
Phase mix: 8 late (III/IV) vs 20 early (I/II) (early-phase heavy).
Top condition: Type 2 Diabetes (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Children's Hospital Los Angeles: open-pipeline peers nationwide
Peers matched on 119 registered trials and 29% open enrollment, not the therapeutic-area sidebar.
Children's Hospital Los Angeles sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 119 trials (± recruiting share)
- Jaeb Center for Health Research · 119 trials · 14% recruiting
- Medtronic - MITG · 119 trials · 4% recruiting
- Michigan State University · 120 trials · 20% recruiting
- San Diego State University · 118 trials · 27% recruiting
Sponsors near 29% open enrollment (± trial volume)
- Natural Immune Systems · 29% recruiting · 17 trials
- Ono Pharmaceutical Co. · 29% recruiting · 17 trials
- Queen's Medical Center · 29% recruiting · 17 trials
- Inova Health Care Services · 29% recruiting · 75 trials
Related
What to do with this Children's Hospital Los Angeles page
119 registered trials is a research-attention snapshot, not an endorsement of Children's Hospital Los Angeles or any single study.
- 35 of Children's Hospital Los Angeles's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 2 Diabetes is the condition Children's Hospital Los Angeles studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Children's Hospital Los Angeles pipeline card: 119 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.